EKF Diagnostics Holdings PLC
LSE:EKF
Balance Sheet
Balance Sheet Decomposition
EKF Diagnostics Holdings PLC
Current Assets | 25.6m |
Cash & Short-Term Investments | 7.7m |
Receivables | 9.1m |
Other Current Assets | 8.8m |
Non-Current Assets | 55.3m |
Long-Term Investments | 276k |
PP&E | 24.8m |
Intangibles | 30.2m |
Other Non-Current Assets | 18k |
Current Liabilities | 9.5m |
Accounts Payable | 5.5m |
Other Current Liabilities | 4m |
Non-Current Liabilities | 4.2m |
Long-Term Debt | 618k |
Other Non-Current Liabilities | 3.6m |
Balance Sheet
EKF Diagnostics Holdings PLC
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
4
|
2
|
8
|
8
|
10
|
12
|
22
|
20
|
9
|
6
|
|
Cash |
4
|
2
|
8
|
8
|
10
|
12
|
0
|
0
|
9
|
6
|
|
Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
22
|
20
|
0
|
0
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Receivables |
16
|
7
|
9
|
7
|
7
|
8
|
13
|
12
|
9
|
9
|
|
Accounts Receivables |
12
|
4
|
6
|
5
|
6
|
6
|
9
|
11
|
8
|
6
|
|
Other Receivables |
4
|
3
|
4
|
2
|
1
|
2
|
4
|
1
|
1
|
3
|
|
Inventory |
6
|
8
|
6
|
6
|
6
|
6
|
8
|
13
|
9
|
9
|
|
Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
5
|
2
|
|
Total Current Assets |
30
|
18
|
23
|
21
|
24
|
26
|
44
|
48
|
32
|
26
|
|
PP&E Net |
11
|
11
|
12
|
12
|
12
|
13
|
14
|
18
|
22
|
25
|
|
PP&E Gross |
11
|
11
|
12
|
12
|
12
|
13
|
14
|
18
|
22
|
25
|
|
Accumulated Depreciation |
6
|
6
|
8
|
9
|
10
|
11
|
12
|
14
|
17
|
17
|
|
Intangible Assets |
48
|
21
|
22
|
19
|
17
|
14
|
13
|
15
|
9
|
6
|
|
Goodwill |
45
|
22
|
25
|
24
|
25
|
24
|
24
|
27
|
25
|
24
|
|
Long-Term Investments |
1
|
0
|
0
|
0
|
3
|
10
|
7
|
8
|
1
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
Other Assets |
45
|
22
|
25
|
24
|
25
|
24
|
24
|
27
|
25
|
24
|
|
Total Assets |
136
N/A
|
72
-47%
|
82
+15%
|
77
-6%
|
81
+5%
|
87
+7%
|
101
+16%
|
115
+14%
|
89
-22%
|
81
-9%
|
|
Liabilities | |||||||||||
Accounts Payable |
2
|
2
|
1
|
1
|
1
|
1
|
2
|
4
|
2
|
1
|
|
Accrued Liabilities |
4
|
5
|
6
|
6
|
6
|
5
|
5
|
4
|
6
|
4
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
4
|
10
|
5
|
0
|
0
|
0
|
1
|
1
|
1
|
3
|
|
Other Current Liabilities |
14
|
4
|
5
|
4
|
6
|
6
|
11
|
4
|
4
|
1
|
|
Total Current Liabilities |
23
|
20
|
17
|
12
|
14
|
12
|
19
|
14
|
12
|
9
|
|
Long-Term Debt |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
|
Deferred Income Tax |
13
|
4
|
4
|
3
|
3
|
3
|
3
|
5
|
2
|
3
|
|
Minority Interest |
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
49
N/A
|
25
-48%
|
22
-13%
|
17
-22%
|
18
+4%
|
17
-7%
|
24
+43%
|
21
-11%
|
16
-24%
|
14
-14%
|
|
Equity | |||||||||||
Common Stock |
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
Retained Earnings |
9
|
45
|
45
|
51
|
53
|
63
|
69
|
79
|
52
|
49
|
|
Additional Paid In Capital |
42
|
91
|
95
|
0
|
0
|
0
|
0
|
7
|
7
|
7
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
4
|
6
|
5
|
6
|
3
|
4
|
3
|
10
|
6
|
|
Total Equity |
87
N/A
|
46
-47%
|
60
+30%
|
60
-1%
|
64
+6%
|
71
+11%
|
78
+10%
|
94
+21%
|
73
-22%
|
67
-8%
|
|
Total Liabilities & Equity |
136
N/A
|
72
-47%
|
82
+15%
|
77
-6%
|
81
+5%
|
87
+7%
|
101
+16%
|
115
+14%
|
89
-22%
|
81
-9%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
422
|
422
|
464
|
458
|
454
|
454
|
455
|
464
|
455
|
454
|